- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Personalized Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Personalized Medicine market size is estimated to be worth US$ 266890 million in 2021 and is forecast to a readjusted size of USD 532910 million by 2028 with a CAGR of 10.4% during review period. Oncology accounting for % of the Personalized Medicine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Personalized Medicine Diagnostics segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Personalized Medicine include Abbott Laboratories, Agilent Technologies, Amgen, Astellas Pharma, and Astrazeneca, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Personalized Medicine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Personalized Medicine Diagnostics
Personalized Medical Care
Personalized Medicine Therapeutics
Personalized Nutrition and Wellness
Market segment by Application, can be divided into
Oncology
Central Nervous System (CNS)
Immunology
Respiratory
Other Applications
Market segment by players, this report covers
Abbott Laboratories
Agilent Technologies
Amgen
Astellas Pharma
Astrazeneca
Bayer AG
Celgene Corporation
Glaxosmithkline Plc
Illumina
Johnson & Johnson
Laboratory Corporation
Merck
Novartis AG
Roche Holding AG
Siemens AG
Takeda Pharmaceutical Company Limited
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Personalized Medicine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Personalized Medicine, with revenue, gross margin and global market share of Personalized Medicine from 2019 to 2022.
Chapter 3, the Personalized Medicine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Personalized Medicine market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Personalized Medicine research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Personalized Medicine
1.2 Classification of Personalized Medicine by Type
1.2.1 Overview: Global Personalized Medicine Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Personalized Medicine Revenue Market Share by Type in 2021
1.2.3 Personalized Medicine Diagnostics
1.2.4 Personalized Medical Care
1.2.5 Personalized Medicine Therapeutics
1.2.6 Personalized Nutrition and Wellness
1.3 Global Personalized Medicine Market by Application
1.3.1 Overview: Global Personalized Medicine Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oncology
1.3.3 Central Nervous System (CNS)
1.3.4 Immunology
1.3.5 Respiratory
1.3.6 Other Applications
1.4 Global Personalized Medicine Market Size & Forecast
1.5 Global Personalized Medicine Market Size and Forecast by Region
1.5.1 Global Personalized Medicine Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Personalized Medicine Market Size by Region, (2017-2022)
1.5.3 North America Personalized Medicine Market Size and Prospect (2017-2028)
1.5.4 Europe Personalized Medicine Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Personalized Medicine Market Size and Prospect (2017-2028)
1.5.6 South America Personalized Medicine Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Personalized Medicine Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Personalized Medicine Market Drivers
1.6.2 Personalized Medicine Market Restraints
1.6.3 Personalized Medicine Trends Analysis
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Personalized Medicine Product and Solutions
2.1.4 Abbott Laboratories Personalized Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Agilent Technologies
2.2.1 Agilent Technologies Details
2.2.2 Agilent Technologies Major Business
2.2.3 Agilent Technologies Personalized Medicine Product and Solutions
2.2.4 Agilent Technologies Personalized Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Agilent Technologies Recent Developments and Future Plans
2.3 Amgen
2.3.1 Amgen Details
2.3.2 Amgen Major Business
2.3.3 Amgen Personalized Medicine Product and Solutions
2.3.4 Amgen Personalized Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Amgen Recent Developments and Future Plans
2.4 Astellas Pharma
2.4.1 Astellas Pharma Details
2.4.2 Astellas Pharma Major Business
2.4.3 Astellas Pharma Personalized Medicine Product and Solutions
2.4.4 Astellas Pharma Personalized Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Astellas Pharma Recent Developments and Future Plans
2.5 Astrazeneca
2.5.1 Astrazeneca Details
2.5.2 Astrazeneca Major Business
2.5.3 Astrazeneca Personalized Medicine Product and Solutions
2.5.4 Astrazeneca Personalized Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Astrazeneca Recent Developments and Future Plans
2.6 Bayer AG
2.6.1 Bayer AG Details
2.6.2 Bayer AG Major Business
2.6.3 Bayer AG Personalized Medicine Product and Solutions
2.6.4 Bayer AG Personalized Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Bayer AG Recent Developments and Future Plans
2.7 Celgene Corporation
2.7.1 Celgene Corporation Details
2.7.2 Celgene Corporation Major Business
2.7.3 Celgene Corporation Personalized Medicine Product and Solutions
2.7.4 Celgene Corporation Personalized Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Celgene Corporation Recent Developments and Future Plans
2.8 Glaxosmithkline Plc
2.8.1 Glaxosmithkline Plc Details
2.8.2 Glaxosmithkline Plc Major Business
2.8.3 Glaxosmithkline Plc Personalized Medicine Product and Solutions
2.8.4 Glaxosmithkline Plc Personalized Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Glaxosmithkline Plc Recent Developments and Future Plans
2.9 Illumina
2.9.1 Illumina Details
2.9.2 Illumina Major Business
2.9.3 Illumina Personalized Medicine Product and Solutions
2.9.4 Illumina Personalized Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Illumina Recent Developments and Future Plans
2.10 Johnson & Johnson
2.10.1 Johnson & Johnson Details
2.10.2 Johnson & Johnson Major Business
2.10.3 Johnson & Johnson Personalized Medicine Product and Solutions
2.10.4 Johnson & Johnson Personalized Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Johnson & Johnson Recent Developments and Future Plans
2.11 Laboratory Corporation
2.11.1 Laboratory Corporation Details
2.11.2 Laboratory Corporation Major Business
2.11.3 Laboratory Corporation Personalized Medicine Product and Solutions
2.11.4 Laboratory Corporation Personalized Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Laboratory Corporation Recent Developments and Future Plans
2.12 Merck
2.12.1 Merck Details
2.12.2 Merck Major Business
2.12.3 Merck Personalized Medicine Product and Solutions
2.12.4 Merck Personalized Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Merck Recent Developments and Future Plans
2.13 Novartis AG
2.13.1 Novartis AG Details
2.13.2 Novartis AG Major Business
2.13.3 Novartis AG Personalized Medicine Product and Solutions
2.13.4 Novartis AG Personalized Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Novartis AG Recent Developments and Future Plans
2.14 Roche Holding AG
2.14.1 Roche Holding AG Details
2.14.2 Roche Holding AG Major Business
2.14.3 Roche Holding AG Personalized Medicine Product and Solutions
2.14.4 Roche Holding AG Personalized Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Roche Holding AG Recent Developments and Future Plans
2.15 Siemens AG
2.15.1 Siemens AG Details
2.15.2 Siemens AG Major Business
2.15.3 Siemens AG Personalized Medicine Product and Solutions
2.15.4 Siemens AG Personalized Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Siemens AG Recent Developments and Future Plans
2.16 Takeda Pharmaceutical Company Limited
2.16.1 Takeda Pharmaceutical Company Limited Details
2.16.2 Takeda Pharmaceutical Company Limited Major Business
2.16.3 Takeda Pharmaceutical Company Limited Personalized Medicine Product and Solutions
2.16.4 Takeda Pharmaceutical Company Limited Personalized Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Takeda Pharmaceutical Company Limited Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Personalized Medicine Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Personalized Medicine Players Market Share in 2021
3.2.2 Top 10 Personalized Medicine Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Personalized Medicine Players Head Office, Products and Services Provided
3.4 Personalized Medicine Mergers & Acquisitions
3.5 Personalized Medicine New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Personalized Medicine Revenue and Market Share by Type (2017-2022)
4.2 Global Personalized Medicine Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Personalized Medicine Revenue Market Share by Application (2017-2022)
5.2 Global Personalized Medicine Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Personalized Medicine Revenue by Type (2017-2028)
6.2 North America Personalized Medicine Revenue by Application (2017-2028)
6.3 North America Personalized Medicine Market Size by Country
6.3.1 North America Personalized Medicine Revenue by Country (2017-2028)
6.3.2 United States Personalized Medicine Market Size and Forecast (2017-2028)
6.3.3 Canada Personalized Medicine Market Size and Forecast (2017-2028)
6.3.4 Mexico Personalized Medicine Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Personalized Medicine Revenue by Type (2017-2028)
7.2 Europe Personalized Medicine Revenue by Application (2017-2028)
7.3 Europe Personalized Medicine Market Size by Country
7.3.1 Europe Personalized Medicine Revenue by Country (2017-2028)
7.3.2 Germany Personalized Medicine Market Size and Forecast (2017-2028)
7.3.3 France Personalized Medicine Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Personalized Medicine Market Size and Forecast (2017-2028)
7.3.5 Russia Personalized Medicine Market Size and Forecast (2017-2028)
7.3.6 Italy Personalized Medicine Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Personalized Medicine Revenue by Type (2017-2028)
8.2 Asia-Pacific Personalized Medicine Revenue by Application (2017-2028)
8.3 Asia-Pacific Personalized Medicine Market Size by Region
8.3.1 Asia-Pacific Personalized Medicine Revenue by Region (2017-2028)
8.3.2 China Personalized Medicine Market Size and Forecast (2017-2028)
8.3.3 Japan Personalized Medicine Market Size and Forecast (2017-2028)
8.3.4 South Korea Personalized Medicine Market Size and Forecast (2017-2028)
8.3.5 India Personalized Medicine Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Personalized Medicine Market Size and Forecast (2017-2028)
8.3.7 Australia Personalized Medicine Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Personalized Medicine Revenue by Type (2017-2028)
9.2 South America Personalized Medicine Revenue by Application (2017-2028)
9.3 South America Personalized Medicine Market Size by Country
9.3.1 South America Personalized Medicine Revenue by Country (2017-2028)
9.3.2 Brazil Personalized Medicine Market Size and Forecast (2017-2028)
9.3.3 Argentina Personalized Medicine Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Personalized Medicine Revenue by Type (2017-2028)
10.2 Middle East & Africa Personalized Medicine Revenue by Application (2017-2028)
10.3 Middle East & Africa Personalized Medicine Market Size by Country
10.3.1 Middle East & Africa Personalized Medicine Revenue by Country (2017-2028)
10.3.2 Turkey Personalized Medicine Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Personalized Medicine Market Size and Forecast (2017-2028)
10.3.4 UAE Personalized Medicine Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Personalized Medicine Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Personalized Medicine Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Personalized Medicine Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Personalized Medicine Revenue (USD Million) by Region (2017-2022)
Table 5. Global Personalized Medicine Revenue Market Share by Region (2023-2028)
Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Laboratories Major Business
Table 8. Abbott Laboratories Personalized Medicine Product and Solutions
Table 9. Abbott Laboratories Personalized Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Agilent Technologies Corporate Information, Head Office, and Major Competitors
Table 11. Agilent Technologies Major Business
Table 12. Agilent Technologies Personalized Medicine Product and Solutions
Table 13. Agilent Technologies Personalized Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Amgen Corporate Information, Head Office, and Major Competitors
Table 15. Amgen Major Business
Table 16. Amgen Personalized Medicine Product and Solutions
Table 17. Amgen Personalized Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Astellas Pharma Corporate Information, Head Office, and Major Competitors
Table 19. Astellas Pharma Major Business
Table 20. Astellas Pharma Personalized Medicine Product and Solutions
Table 21. Astellas Pharma Personalized Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Astrazeneca Corporate Information, Head Office, and Major Competitors
Table 23. Astrazeneca Major Business
Table 24. Astrazeneca Personalized Medicine Product and Solutions
Table 25. Astrazeneca Personalized Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Bayer AG Corporate Information, Head Office, and Major Competitors
Table 27. Bayer AG Major Business
Table 28. Bayer AG Personalized Medicine Product and Solutions
Table 29. Bayer AG Personalized Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Celgene Corporation Corporate Information, Head Office, and Major Competitors
Table 31. Celgene Corporation Major Business
Table 32. Celgene Corporation Personalized Medicine Product and Solutions
Table 33. Celgene Corporation Personalized Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Glaxosmithkline Plc Corporate Information, Head Office, and Major Competitors
Table 35. Glaxosmithkline Plc Major Business
Table 36. Glaxosmithkline Plc Personalized Medicine Product and Solutions
Table 37. Glaxosmithkline Plc Personalized Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Illumina Corporate Information, Head Office, and Major Competitors
Table 39. Illumina Major Business
Table 40. Illumina Personalized Medicine Product and Solutions
Table 41. Illumina Personalized Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 43. Johnson & Johnson Major Business
Table 44. Johnson & Johnson Personalized Medicine Product and Solutions
Table 45. Johnson & Johnson Personalized Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Laboratory Corporation Corporate Information, Head Office, and Major Competitors
Table 47. Laboratory Corporation Major Business
Table 48. Laboratory Corporation Personalized Medicine Product and Solutions
Table 49. Laboratory Corporation Personalized Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Merck Corporate Information, Head Office, and Major Competitors
Table 51. Merck Major Business
Table 52. Merck Personalized Medicine Product and Solutions
Table 53. Merck Personalized Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Novartis AG Corporate Information, Head Office, and Major Competitors
Table 55. Novartis AG Major Business
Table 56. Novartis AG Personalized Medicine Product and Solutions
Table 57. Novartis AG Personalized Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Roche Holding AG Corporate Information, Head Office, and Major Competitors
Table 59. Roche Holding AG Major Business
Table 60. Roche Holding AG Personalized Medicine Product and Solutions
Table 61. Roche Holding AG Personalized Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Siemens AG Corporate Information, Head Office, and Major Competitors
Table 63. Siemens AG Major Business
Table 64. Siemens AG Personalized Medicine Product and Solutions
Table 65. Siemens AG Personalized Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Takeda Pharmaceutical Company Limited Corporate Information, Head Office, and Major Competitors
Table 67. Takeda Pharmaceutical Company Limited Major Business
Table 68. Takeda Pharmaceutical Company Limited Personalized Medicine Product and Solutions
Table 69. Takeda Pharmaceutical Company Limited Personalized Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Global Personalized Medicine Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 71. Global Personalized Medicine Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 72. Breakdown of Personalized Medicine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 73. Personalized Medicine Players Head Office, Products and Services Provided
Table 74. Personalized Medicine Mergers & Acquisitions in the Past Five Years
Table 75. Personalized Medicine New Entrants and Expansion Plans
Table 76. Global Personalized Medicine Revenue (USD Million) by Type (2017-2022)
Table 77. Global Personalized Medicine Revenue Share by Type (2017-2022)
Table 78. Global Personalized Medicine Revenue Forecast by Type (2023-2028)
Table 79. Global Personalized Medicine Revenue by Application (2017-2022)
Table 80. Global Personalized Medicine Revenue Forecast by Application (2023-2028)
Table 81. North America Personalized Medicine Revenue by Type (2017-2022) & (USD Million)
Table 82. North America Personalized Medicine Revenue by Type (2023-2028) & (USD Million)
Table 83. North America Personalized Medicine Revenue by Application (2017-2022) & (USD Million)
Table 84. North America Personalized Medicine Revenue by Application (2023-2028) & (USD Million)
Table 85. North America Personalized Medicine Revenue by Country (2017-2022) & (USD Million)
Table 86. North America Personalized Medicine Revenue by Country (2023-2028) & (USD Million)
Table 87. Europe Personalized Medicine Revenue by Type (2017-2022) & (USD Million)
Table 88. Europe Personalized Medicine Revenue by Type (2023-2028) & (USD Million)
Table 89. Europe Personalized Medicine Revenue by Application (2017-2022) & (USD Million)
Table 90. Europe Personalized Medicine Revenue by Application (2023-2028) & (USD Million)
Table 91. Europe Personalized Medicine Revenue by Country (2017-2022) & (USD Million)
Table 92. Europe Personalized Medicine Revenue by Country (2023-2028) & (USD Million)
Table 93. Asia-Pacific Personalized Medicine Revenue by Type (2017-2022) & (USD Million)
Table 94. Asia-Pacific Personalized Medicine Revenue by Type (2023-2028) & (USD Million)
Table 95. Asia-Pacific Personalized Medicine Revenue by Application (2017-2022) & (USD Million)
Table 96. Asia-Pacific Personalized Medicine Revenue by Application (2023-2028) & (USD Million)
Table 97. Asia-Pacific Personalized Medicine Revenue by Region (2017-2022) & (USD Million)
Table 98. Asia-Pacific Personalized Medicine Revenue by Region (2023-2028) & (USD Million)
Table 99. South America Personalized Medicine Revenue by Type (2017-2022) & (USD Million)
Table 100. South America Personalized Medicine Revenue by Type (2023-2028) & (USD Million)
Table 101. South America Personalized Medicine Revenue by Application (2017-2022) & (USD Million)
Table 102. South America Personalized Medicine Revenue by Application (2023-2028) & (USD Million)
Table 103. South America Personalized Medicine Revenue by Country (2017-2022) & (USD Million)
Table 104. South America Personalized Medicine Revenue by Country (2023-2028) & (USD Million)
Table 105. Middle East & Africa Personalized Medicine Revenue by Type (2017-2022) & (USD Million)
Table 106. Middle East & Africa Personalized Medicine Revenue by Type (2023-2028) & (USD Million)
Table 107. Middle East & Africa Personalized Medicine Revenue by Application (2017-2022) & (USD Million)
Table 108. Middle East & Africa Personalized Medicine Revenue by Application (2023-2028) & (USD Million)
Table 109. Middle East & Africa Personalized Medicine Revenue by Country (2017-2022) & (USD Million)
Table 110. Middle East & Africa Personalized Medicine Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Personalized Medicine Picture
Figure 2. Global Personalized Medicine Revenue Market Share by Type in 2021
Figure 3. Personalized Medicine Diagnostics
Figure 4. Personalized Medical Care
Figure 5. Personalized Medicine Therapeutics
Figure 6. Personalized Nutrition and Wellness
Figure 7. Personalized Medicine Revenue Market Share by Application in 2021
Figure 8. Oncology Picture
Figure 9. Central Nervous System (CNS) Picture
Figure 10. Immunology Picture
Figure 11. Respiratory Picture
Figure 12. Other Applications Picture
Figure 13. Global Personalized Medicine Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 14. Global Personalized Medicine Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Personalized Medicine Revenue Market Share by Region (2017-2028)
Figure 16. Global Personalized Medicine Revenue Market Share by Region in 2021
Figure 17. North America Personalized Medicine Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Europe Personalized Medicine Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Asia-Pacific Personalized Medicine Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. South America Personalized Medicine Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Middle East and Africa Personalized Medicine Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Personalized Medicine Market Drivers
Figure 23. Personalized Medicine Market Restraints
Figure 24. Personalized Medicine Market Trends
Figure 25. Abbott Laboratories Recent Developments and Future Plans
Figure 26. Agilent Technologies Recent Developments and Future Plans
Figure 27. Amgen Recent Developments and Future Plans
Figure 28. Astellas Pharma Recent Developments and Future Plans
Figure 29. Astrazeneca Recent Developments and Future Plans
Figure 30. Bayer AG Recent Developments and Future Plans
Figure 31. Celgene Corporation Recent Developments and Future Plans
Figure 32. Glaxosmithkline Plc Recent Developments and Future Plans
Figure 33. Illumina Recent Developments and Future Plans
Figure 34. Johnson & Johnson Recent Developments and Future Plans
Figure 35. Laboratory Corporation Recent Developments and Future Plans
Figure 36. Merck Recent Developments and Future Plans
Figure 37. Novartis AG Recent Developments and Future Plans
Figure 38. Roche Holding AG Recent Developments and Future Plans
Figure 39. Siemens AG Recent Developments and Future Plans
Figure 40. Takeda Pharmaceutical Company Limited Recent Developments and Future Plans
Figure 41. Global Personalized Medicine Revenue Share by Players in 2021
Figure 42. Personalized Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 43. Global Top 3 Players Personalized Medicine Revenue Market Share in 2021
Figure 44. Global Top 10 Players Personalized Medicine Revenue Market Share in 2021
Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 46. Global Personalized Medicine Revenue Share by Type in 2021
Figure 47. Global Personalized Medicine Market Share Forecast by Type (2023-2028)
Figure 48. Global Personalized Medicine Revenue Share by Application in 2021
Figure 49. Global Personalized Medicine Market Share Forecast by Application (2023-2028)
Figure 50. North America Personalized Medicine Sales Market Share by Type (2017-2028)
Figure 51. North America Personalized Medicine Sales Market Share by Application (2017-2028)
Figure 52. North America Personalized Medicine Revenue Market Share by Country (2017-2028)
Figure 53. United States Personalized Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Canada Personalized Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Mexico Personalized Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Europe Personalized Medicine Sales Market Share by Type (2017-2028)
Figure 57. Europe Personalized Medicine Sales Market Share by Application (2017-2028)
Figure 58. Europe Personalized Medicine Revenue Market Share by Country (2017-2028)
Figure 59. Germany Personalized Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. France Personalized Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. United Kingdom Personalized Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Russia Personalized Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Italy Personalized Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Asia-Pacific Personalized Medicine Sales Market Share by Type (2017-2028)
Figure 65. Asia-Pacific Personalized Medicine Sales Market Share by Application (2017-2028)
Figure 66. Asia-Pacific Personalized Medicine Revenue Market Share by Region (2017-2028)
Figure 67. China Personalized Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Japan Personalized Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South Korea Personalized Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. India Personalized Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Southeast Asia Personalized Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Australia Personalized Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. South America Personalized Medicine Sales Market Share by Type (2017-2028)
Figure 74. South America Personalized Medicine Sales Market Share by Application (2017-2028)
Figure 75. South America Personalized Medicine Revenue Market Share by Country (2017-2028)
Figure 76. Brazil Personalized Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Argentina Personalized Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Middle East and Africa Personalized Medicine Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Personalized Medicine Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Personalized Medicine Revenue Market Share by Country (2017-2028)
Figure 81. Turkey Personalized Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Saudi Arabia Personalized Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. UAE Personalized Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. Methodology
Figure 85. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
